On June 9, 2025, HHS removed all members of the CDC’s vaccine advisory committee (ACIP), citing the need to restore public trust and eliminate conflicts of interest. Learn what this change could mean for healthcare payers, providers, and immunization policy in the U.S.
Aphasia affects millions of Americans, yet it often goes unrecognized in healthcare settings. This article explores the causes and emotional impact of aphasia, highlights compassionate communication strategies, and outlines therapeutic interventions to support recovery and improve patient outcomes.
The FDA has approved Google’s Pixel Watch 3 for loss-of-pulse detection, marking a major step in wearable health tech.
Could AI soon prescribe medications? H.R. 238 raises crucial questions about the role of artificial intelligence in healthcare decision-making.
Strategies for balancing cost containment and quality care in healthcare. Explore methods executives can employ to optimize resources, enhance efficiency, and sustain financial stability while delivering exceptional patient outcomes.
On December 10, 2024, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule introducing significant policy and technical changes to the Medicare Advantage (MA) Program, Medicare Prescription Drug Benefit Program (Part D), Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (PACE) for Contract Year 2026.
Recent AI legislation suggests an increase in regulations on the horizon, particularly concerning high-risk applications like healthcare. Is your organization prepared to comply?
Part 1 of 2 Analyze recent data on AI hallucination in healthcare, exploring its occurrence, implications, and strategies to mitigate associated risks.
An analysis of recent data on AI hallucination in healthcare, exploring its occurrence, implications, and strategies to mitigate associated risks.
Copyright 2025 © All rights Reserved.
